Monthly Archives: January 2010
Help With Medical Bills (WSJ.com)
A diagnosis of cancer or other serious disease can be devastating to one’s financial as well as physical health — even for people with insurance. But there are a handful of programs that can help ease the monetary burden. The … Continue reading
Symptoms Alone Don’t Spot Ovarian Cancer Early
Relying on symptoms alone to identify women who have ovarian cancer isn’t very effective at catching the disease early, a new study indicates. Research shows that women with ovarian cancer are much more likely than healthy women to report symptoms … Continue reading
Posted in News Leave a comment
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines for Oncology™ for Ovarian Cancer to reflect the addition of two preferred combination regimens for a specific cohort of patients based on data from recent clinical research … Continue reading
MRI, CT, and PET/CT for Ovarian Cancer Detection and Adnexal Lesion Characterization (Am. J. of Roentgenology)
OBJECTIVE. The purpose of this article is to describe the role of MR, CT, and PET/CT in the detection of ovarian cancer and the evaluation of adnexal lesions. CONCLUSION. The goal of imaging in ovarian cancer detection is to expeditiously … Continue reading
Clinical Decision Making Using Ovarian Cancer Risk Assessment (Am. J. of Roentgenology)
OBJECTIVE. Although any adnexal abnormality found at imaging can be concerning for an ovarian malignancy, the clinician must perform an evaluation to decide if the actual likelihood of malignancy justifies the risk of surgery. When determining the likelihood of an … Continue reading
Posted in News Leave a comment
Risk Assessment and Genetic Testing for Ovarian Cancer (Am. J. of Roentgenology)
OBJECTIVE. Prevention of ovarian cancer starts with identifying women at high risk for this deadly disease. Once identified, these women can be offered risk-reducing options such as oral contraceptives and bilateral salpingo-oophorectomy. In this review, strategies for identifying high-risk individuals … Continue reading
Posted in News Leave a comment
Combo Test Might Spot Ovarian Cancer Early
The ability to detect early-stage ovarian cancer may be improved by using contrast-enhanced ultrasound combined with proteomic analyses of blood samples, a new study shows. Proteomics is the study of proteins, particularly their structure and function. Hundreds of proteins have … Continue reading
Posted in News Leave a comment
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
Background: The objective of the study was to estimate the antitumor activity of pemetrexed in patients with advanced/recurrent carcinoma of the cervix and to determine the nature and degree of toxicity. Methods: A multicenter phase II trial was conducted by … Continue reading
Posted in News Leave a comment
Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary
Background: The aim of this study was to assess the outcomes of the largest series of patients treated conservatively for a stage II or III serous borderline ovarian tumor. Materials and methods: From 1969 to 2006, 41 patients were treated … Continue reading
Clinical Presentation of Endometrioid Epithelial Ovarian Cancer with Concurrent Endometriosis: A Multicenter Retrospective Study (Cancer Epidemiol Biomarkers Prev)
Background: Endometrioid epithelial ovarian cancer (EEOC) is frequently diagnosed in conjunction with endometriosis and is suggested to arise during the process of endometriosis. This study evaluates the clinical manifestations, including endometriosis-related symptoms and their relationships according to the coexistence of … Continue reading
Posted in News Leave a comment
Participatory medicine: A high-tech alliance with patients (American Medical News)
Information technology is making patient participation in medicine more workable — and possibly more financially advantageous to doctors and patients. As physicians experience mounting pressure to contain costs and improve outcomes while their patient loads increase, many are finding that … Continue reading
Posted in News Leave a comment
Abbott gets European approval for cancer test
Medical product and drug developer Abbott Laboratories said Thursday European regulators have approved the company’s ovarian cancer test. The company’s human epididymis protein 4, or HE4, test is cleared for sale in Europe. The test runs on the company’s Architect … Continue reading
Posted in News Leave a comment
